by Stacey Johnson | Jan 2, 2025
Happy New Year! With so much information available online, thank you for choosing to read the content on Signals. Whether you are a subscriber and a loyal reader, or you follow a particular blogger or category, your readership is appreciated! As of this writing, here...
by Stacey Johnson | Oct 25, 2024
Michel Sadelain is the 2024 Gairdner International Award laureate, along with Dr. Zelig Eshhar, for his “seminal contributions to the conception, development and application of CD19-CAR T cell therapy for cancer.” It’s been a good year for Dr. Sadelain, who also won...
by Stacey Johnson | Aug 2, 2024
He’s back! The regenerative medicine (RM) field’s unofficial mascot – Deadpool – is back in theatres and all over media and social media due to what one must assume is a super(hero)-sized marketing budget. Although some may disagree on his status as a mascot, you...
by Stacey Johnson | Jul 26, 2024
An assassination attempt on former president Donald Trump and President Joe Biden removing himself from the race and endorsing Vice President Kamala Harris has meant the last two weeks have been filled with election news. We can be certain that the coverage won’t stop...
by Stacey Johnson | Jun 28, 2024
As June comes to an end, so does Pride Month in Canada. In 12 years of blogging for Signals, I realize I have never covered the topic of STEM (science, technology, engineering and mathematics) and Pride, although I have written about Equity, Diversity and Inclusion...
by Stacey Johnson | Mar 29, 2024
Dr. Michel Sadelain, the “inventor of T cells” and a graduate of the University of Alberta, has won the 2024 Breakthrough Prize in life sciences. After completing his medical degree at the University of Paris, Dr. Sadelain earned his PhD in immunology at the...
Comments